In a statement, AbbVie said that its phase 2 trial investigating emraclidine as a once-daily oral monotherapy treatment for adults with schizophrenia ... pointing to the recent Food and Drug ...
Many popular cold and flu remedies may be pulled from US shelves after, the Food and Drug Administration (FDA) deemed oral phenylephrine ineffective as a nasal decongestant. Phenylephrine is the main ...
At a meeting of the Food and Drug Administration’s (FDA) Endocrinologic and Metabolic Drugs Advisory Committee ... On the question of whether the benefits of sotagliflozin, an oral dual sodium-glucose ...
In February 2024, the FDA put two Phase II studies of zelnecirnon under a clinical hold after a case of liver failure was deemed potentially related to the drug.
Just as cold and flu season arrives, the Food and Drug Administration proposes pulling many decongestants from store shelves. The reason? An administration review found oral phenylephrine — a common ...